Skip to main content
    I

    InnovAge Holding Corp (INNV)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $9.58
    +0.11 (+1.16%)

    Market Cap: $1.29B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    InnovAge Holding Corp (INNV) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect InnovAge Holding (INNV) to earn $0.45 per share in the fiscal year ending Jun 30, 2027, on revenue of $1.08B. Of 3 analysts, 1 rates the stock Buy or Strong Buy, 1 Hold and 1 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Jun 30, 2027 was revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 3.33, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 33% of the ratings.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy133.3%
    Hold133.3%
    Sell00.0%
    Strong Sell133.3%
    Consensus
    Hold
    Total analysts
    3

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 11.1% and revenue estimates rise 7.4%.

    Fiscal year ending Jun 30, 2027
    $0.45
    EPS consensus, revenue $1.08B
    Fiscal year ending Jun 30, 2028
    $0.50
    EPS consensus, revenue $1.16B
    Next report
    Feb 1, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Jun 30, 2027$0.45$0.45 to $0.451$1.08B$1.07B to $1.08B3
    Jun 30, 2028$0.50$0.50 to $0.501$1.16B$1.16B to $1.17B3

    Quarterly Estimates

    Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Dec 31, 2026, at $0.09, and highest for the quarter ending Mar 31, 2027, at $0.13.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.09$0.09 to $0.091$261.10M$260.00M to $262.20M2
    Mar 31, 2027$0.13$0.13 to $0.131$272.30M$271.00M to $273.60M2
    Jun 30, 2027$0.11$0.09 to $0.145$284.79M$270.10M to $296.94M5

    Estimate Revisions

    Across the 4 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Jun 30, 202710
    Fiscal year ending Jun 30, 202810
    Quarter ending Dec 31, 202600
    Quarter ending Mar 31, 202700

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Jun 30, 2027 has risen 18.4% from $0.38.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Jun 30, 2027$0.45$0.41$0.41$0.38$0.38+18.4%
    Fiscal year ending Jun 30, 2028$0.50$0.46$0.46N/AN/AN/A
    Quarter ending Dec 31, 2026$0.09$0.10N/A$0.09$0.090.0%
    Quarter ending Mar 31, 2027$0.13$0.13N/A$0.13$0.130.0%

    Frequently Asked Questions About INNV

    What is the INNV stock forecast?

    Consensus analyst estimates put InnovAge Holding's EPS at $0.45 for the fiscal year ending Jun 30, 2027, on revenue of $1.08B. The consensus rating from 3 analysts is Hold.

    How do analysts rate INNV stock?

    Of 3 analysts covering InnovAge Holding, 0 rate it Strong Buy, 1 Buy, 1 Hold, 0 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from INNV next year?

    For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is $0.45, with estimates from $0.45 to $0.45 from 1 analyst. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is $0.50, with estimates from $0.50 to $0.50 from 1 analyst.

    What revenue do analysts expect from InnovAge Holding next year?

    For the fiscal year ending Jun 30, 2027, the consensus revenue estimate is $1.08B, with estimates from $1.07B to $1.08B. For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $1.16B, with estimates from $1.16B to $1.17B.

    How many analysts cover INNV?

    3 analysts rate InnovAge Holding stock, and 1 analyst estimates its EPS for the fiscal year ending Jun 30, 2027.